1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Sturge Weber Syndrome (SWS) Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Medication 1.2.3 Laser Therapy 1.2.4 Surgical Procedures 1.3 Market by Application 1.3.1 Global Sturge Weber Syndrome (SWS) Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Diagnostic Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Sturge Weber Syndrome (SWS) Treatment Market Perspective (2017-2028) 2.2 Sturge Weber Syndrome (SWS) Treatment Growth Trends by Region 2.2.1 Sturge Weber Syndrome (SWS) Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Sturge Weber Syndrome (SWS) Treatment Historic Market Size by Region (2017-2022) 2.2.3 Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Region (2023-2028) 2.3 Sturge Weber Syndrome (SWS) Treatment Market Dynamics 2.3.1 Sturge Weber Syndrome (SWS) Treatment Industry Trends 2.3.2 Sturge Weber Syndrome (SWS) Treatment Market Drivers 2.3.3 Sturge Weber Syndrome (SWS) Treatment Market Challenges 2.3.4 Sturge Weber Syndrome (SWS) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Sturge Weber Syndrome (SWS) Treatment Players by Revenue 3.1.1 Global Top Sturge Weber Syndrome (SWS) Treatment Players by Revenue (2017-2022) 3.1.2 Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Sturge Weber Syndrome (SWS) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Sturge Weber Syndrome (SWS) Treatment Revenue 3.4 Global Sturge Weber Syndrome (SWS) Treatment Market Concentration Ratio 3.4.1 Global Sturge Weber Syndrome (SWS) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Sturge Weber Syndrome (SWS) Treatment Revenue in 2021 3.5 Sturge Weber Syndrome (SWS) Treatment Key Players Head office and Area Served 3.6 Key Players Sturge Weber Syndrome (SWS) Treatment Product Solution and Service 3.7 Date of Enter into Sturge Weber Syndrome (SWS) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Sturge Weber Syndrome (SWS) Treatment Breakdown Data by Type 4.1 Global Sturge Weber Syndrome (SWS) Treatment Historic Market Size by Type (2017-2022) 4.2 Global Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Type (2023-2028) 5 Sturge Weber Syndrome (SWS) Treatment Breakdown Data by Application 5.1 Global Sturge Weber Syndrome (SWS) Treatment Historic Market Size by Application (2017-2022) 5.2 Global Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Sturge Weber Syndrome (SWS) Treatment Market Size (2017-2028) 6.2 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2017-2022) 6.3 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Sturge Weber Syndrome (SWS) Treatment Market Size (2017-2028) 7.2 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2017-2022) 7.3 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size (2017-2028) 8.2 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size (2017-2028) 9.2 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2017-2022) 9.3 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size (2017-2028) 10.2 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Abbott 11.1.1 Abbott Company Detail 11.1.2 Abbott Business Overview 11.1.3 Abbott Sturge Weber Syndrome (SWS) Treatment Introduction 11.1.4 Abbott Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.1.5 Abbott Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Detail 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Sturge Weber Syndrome (SWS) Treatment Introduction 11.2.4 Pfizer Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.2.5 Pfizer Recent Development 11.3 Roche 11.3.1 Roche Company Detail 11.3.2 Roche Business Overview 11.3.3 Roche Sturge Weber Syndrome (SWS) Treatment Introduction 11.3.4 Roche Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.3.5 Roche Recent Development 11.4 Novartis 11.4.1 Novartis Company Detail 11.4.2 Novartis Business Overview 11.4.3 Novartis Sturge Weber Syndrome (SWS) Treatment Introduction 11.4.4 Novartis Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.4.5 Novartis Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Detail 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Sturge Weber Syndrome (SWS) Treatment Introduction 11.5.4 Johnson & Johnson Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.5.5 Johnson & Johnson Recent Development 11.6 UCB 11.6.1 UCB Company Detail 11.6.2 UCB Business Overview 11.6.3 UCB Sturge Weber Syndrome (SWS) Treatment Introduction 11.6.4 UCB Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.6.5 UCB Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Detail 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Sturge Weber Syndrome (SWS) Treatment Introduction 11.7.4 Sanofi Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.7.5 Sanofi Recent Development 11.8 Takeda 11.8.1 Takeda Company Detail 11.8.2 Takeda Business Overview 11.8.3 Takeda Sturge Weber Syndrome (SWS) Treatment Introduction 11.8.4 Takeda Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.8.5 Takeda Recent Development 11.9 Aleva Neurotherapeutics 11.9.1 Aleva Neurotherapeutics Company Detail 11.9.2 Aleva Neurotherapeutics Business Overview 11.9.3 Aleva Neurotherapeutics Sturge Weber Syndrome (SWS) Treatment Introduction 11.9.4 Aleva Neurotherapeutics Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.9.5 Aleva Neurotherapeutics Recent Development 11.10 GW Pharmaceuticals 11.10.1 GW Pharmaceuticals Company Detail 11.10.2 GW Pharmaceuticals Business Overview 11.10.3 GW Pharmaceuticals Sturge Weber Syndrome (SWS) Treatment Introduction 11.10.4 GW Pharmaceuticals Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.10.5 GW Pharmaceuticals Recent Development 11.11 ElectroCore 11.11.1 ElectroCore Company Detail 11.11.2 ElectroCore Business Overview 11.11.3 ElectroCore Sturge Weber Syndrome (SWS) Treatment Introduction 11.11.4 ElectroCore Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) 11.11.5 ElectroCore Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Sturge Weber Syndrome (SWS) Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Medication Table 3. Key Players of Laser Therapy Table 4. Key Players of Surgical Procedures Table 5. Global Sturge Weber Syndrome (SWS) Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Sturge Weber Syndrome (SWS) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Sturge Weber Syndrome (SWS) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Region (2017-2022) Table 9. Global Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Region (2023-2028) Table 11. Sturge Weber Syndrome (SWS) Treatment Market Trends Table 12. Sturge Weber Syndrome (SWS) Treatment Market Drivers Table 13. Sturge Weber Syndrome (SWS) Treatment Market Challenges Table 14. Sturge Weber Syndrome (SWS) Treatment Market Restraints Table 15. Global Sturge Weber Syndrome (SWS) Treatment Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Players (2017-2022) Table 17. Global Top Sturge Weber Syndrome (SWS) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sturge Weber Syndrome (SWS) Treatment as of 2021) Table 18. Ranking of Global Top Sturge Weber Syndrome (SWS) Treatment Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Sturge Weber Syndrome (SWS) Treatment Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Sturge Weber Syndrome (SWS) Treatment Product Solution and Service Table 22. Date of Enter into Sturge Weber Syndrome (SWS) Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Type (2017-2022) Table 26. Global Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Type (2023-2028) Table 28. Global Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Application (2017-2022) Table 30. Global Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Application (2023-2028) Table 32. North America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 42. Abbott Company Detail Table 43. Abbott Business Overview Table 44. Abbott Sturge Weber Syndrome (SWS) Treatment Product Table 45. Abbott Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 46. Abbott Recent Development Table 47. Pfizer Company Detail Table 48. Pfizer Business Overview Table 49. Pfizer Sturge Weber Syndrome (SWS) Treatment Product Table 50. Pfizer Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 51. Pfizer Recent Development Table 52. Roche Company Detail Table 53. Roche Business Overview Table 54. Roche Sturge Weber Syndrome (SWS) Treatment Product Table 55. Roche Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 56. Roche Recent Development Table 57. Novartis Company Detail Table 58. Novartis Business Overview Table 59. Novartis Sturge Weber Syndrome (SWS) Treatment Product Table 60. Novartis Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 61. Novartis Recent Development Table 62. Johnson & Johnson Company Detail Table 63. Johnson & Johnson Business Overview Table 64. Johnson & Johnson Sturge Weber Syndrome (SWS) Treatment Product Table 65. Johnson & Johnson Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 66. Johnson & Johnson Recent Development Table 67. UCB Company Detail Table 68. UCB Business Overview Table 69. UCB Sturge Weber Syndrome (SWS) Treatment Product Table 70. UCB Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 71. UCB Recent Development Table 72. Sanofi Company Detail Table 73. Sanofi Business Overview Table 74. Sanofi Sturge Weber Syndrome (SWS) Treatment Product Table 75. Sanofi Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 76. Sanofi Recent Development Table 77. Takeda Company Detail Table 78. Takeda Business Overview Table 79. Takeda Sturge Weber Syndrome (SWS) Treatment Product Table 80. Takeda Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 81. Takeda Recent Development Table 82. Aleva Neurotherapeutics Company Detail Table 83. Aleva Neurotherapeutics Business Overview Table 84. Aleva Neurotherapeutics Sturge Weber Syndrome (SWS) Treatment Product Table 85. Aleva Neurotherapeutics Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 86. Aleva Neurotherapeutics Recent Development Table 87. GW Pharmaceuticals Company Detail Table 88. GW Pharmaceuticals Business Overview Table 89. GW Pharmaceuticals Sturge Weber Syndrome (SWS) Treatment Product Table 90. GW Pharmaceuticals Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 91. GW Pharmaceuticals Recent Development Table 92. ElectroCore Company Detail Table 93. ElectroCore Business Overview Table 94. ElectroCore Sturge Weber Syndrome (SWS) TreatmentProduct Table 95. ElectroCore Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) & (US$ Million) Table 96. ElectroCore Recent Development Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Type: 2021 VS 2028 Figure 2. Medication Features Figure 3. Laser Therapy Features Figure 4. Surgical Procedures Features Figure 5. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Application in 2021 & 2028 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Diagnostic Centers Case Studies Figure 9. Others Case Studies Figure 10. Sturge Weber Syndrome (SWS) Treatment Report Years Considered Figure 11. Global Sturge Weber Syndrome (SWS) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Sturge Weber Syndrome (SWS) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Region: 2021 VS 2028 Figure 14. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Players in 2021 Figure 15. Global Top Sturge Weber Syndrome (SWS) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sturge Weber Syndrome (SWS) Treatment as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Sturge Weber Syndrome (SWS) Treatment Revenue in 2021 Figure 17. North America Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Sturge Weber Syndrome (SWS) Treatment Market Share by Country (2017-2028) Figure 19. United States Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Sturge Weber Syndrome (SWS) Treatment Market Share by Country (2017-2028) Figure 23. Germany Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Share by Region (2017-2028) Figure 31. China Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Sturge Weber Syndrome (SWS) Treatment Market Share by Country (2017-2028) Figure 39. Mexico Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Share by Country (2017-2028) Figure 43. Turkey Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Abbott Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 46. Pfizer Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 47. Roche Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 48. Novartis Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 49. Johnson & Johnson Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 50. UCB Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 51. Sanofi Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 52. Takeda Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 53. Aleva Neurotherapeutics Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 54. GW Pharmaceuticals Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 55. ElectroCore Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Abbott Pfizer Roche Novartis Johnson & Johnson UCB Sanofi Takeda Aleva Neurotherapeutics GW Pharmaceuticals ElectroCore